The Effects of NLY01, a Novel Glucagon-Like Peptide-1 Receptor Agonist, on Cuprizone-Induced Demyelination and Remyelination: Challenges and Future Perspectives

enthalten in: NeuroRX | 2023

von Gharagozloo, M. | Galleguillos, D. | Jank, L. | +13